Prince Paul
Nurse Practitioner · Houston, TXNPI 1073746012
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,201 of the $1,749 with a category attached, or 68.7%. 14 manufacturers reported payments, led by Astellas Pharma US Inc at 29.2% of the total. 2025 is the largest year on record at $813, 4.1 times the $199 reported in 2021.
Across 36 payments — averaging $48.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$511
- Incyte Corporation$290
- Sanofi-aventis U.S. LLC$261
- Jazz Pharmaceuticals Inc.$167
- UCB, Inc.$100
- Johnson & Johnson$96
- plus $324 from 8 others
What the payments were for
- Food & beverage$1,20169%
- Education$54831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $511 |
| Incyte Corporation | 5 | $290 |
| Sanofi-aventis U.S. LLC | 4 | $261 |
| Jazz Pharmaceuticals Inc. | 2 | $167 |
| UCB, Inc. | 1 | $100 |
| Johnson & Johnson | 3 | $96 |
| Bristol Myers Squibb | 4 | $79 |
| Merck | 2 | $69 |
| Taiho Oncology, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Sobi, Inc | 1 | $29 |
| Invivyd Inc | 1 | $29 |
| AbbVie | 1 | $27 |
| Gamida Cell Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,749 in reported general payments places this provider in the 85th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Houston
- Melanie MorrisHouston$254K
- Julie WeatherlyHouston$87K
- Katrina KingHouston$44K
- Allison TurnerHouston$37K
- Tiffany RichardsHouston$37K
- Bianca CaloHouston$36K
- Arby CohenHouston$23K
- Virginia MarxHouston$19K
- Hermeyone BellHouston$17K
- Cecilia DavisAustin$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.